MarketInOut Stock Screener Log In | Sign Up

hVIVO Plc

LSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 16:41
hVIVO Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeLSE
Market Capitalization38.21 mln
Float659 mln
Earnings Date04/14/2027

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-2.42
Borderline

1-Year Forecast

15.50
Transformational upside

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.43
Low leverage

Pre-Tax Margin

-31%
Deeply loss-making

Business Description

hVIVO plc is a London-based contract research organization that helps pharmaceutical and biotech companies develop and test vaccines and antiviral treatments. The company runs human challenge trials, where carefully screened volunteers are exposed to controlled infections, allowing researchers to study diseases like influenza, RSV, and COVID-19 in a precise and measurable setting. hVIVO also provides a broad range of supporting laboratory and clinical services, covering everything from early drug discovery through to data analysis and regulatory consultancy.

Key Fundamentals

EPS-2.00
ROE-32.54
RPS0.06
ROIC-24.56
ROA-16.01
Interest Cover-15.12
EBITDA, mln-5.85
EV / EBITDA-7.21
EV / EBIT-3.84
Revenue, mln38.85
EV / Revenue1.09

Quote Details

Last 5.55
Change 0.07 (1.28%)
Open 5.48
Volume 724,338
Turnover 4,020,076
Average Volume 1,065,509

Financial Ratios

Pre-Tax Profit Margin-31
Leverage Ratio2.28
Current Ratio1.21
Price / Book1.33
Price / Tangible Book3.14
Debt / Equity0.43
Price / Sales1.10

Financial Strength

Altman Z-Score1.98
Piotroski F-Score 1 / 9
Beneish M-Score-2.42
Price to Intrinsic Value0.57
1-Year Target Price15.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.8% 10 / 100   
1 Month -7.5% 15 / 100   
2 Months -17.16% 8 / 100   
6 Months -26% 8 / 100   
1 Year -15.91% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog